Nu Skin Enterprises (NYSE: NUS) reported Q2 EPS of $0.75, $0.03 better than the analyst estimate of $0.72. Revenue for the quarter came in at $560.2 million versus the consensus estimate of $550.81 million.

Nu Skin Enterprises sees Q3 2015 EPS of $0.96-$1.00, versus the consensus of $1.11. Nu Skin Enterprises sees Q3 2015 revenue of $600-620 million, versus the consensus of $648.1 million.

Nu Skin Enterprises sees FY2015 EPS of $3.59-$3.67, versus the consensus of $3.66. Nu Skin Enterprises sees FY2015 revenue of $2.4-2.44 billion, versus the consensus of $2.43 billion.

"We are pleased the business performed at the high end of our expectations for the second quarter," said Truman Hunt, president and chief executive officer. "Additionally, we are encouraged by growth in the number of sales leaders sequentially, including a 19 percent increase in sales leaders in Mainland China. We believe that this trend signals growing sales leader energy as we build toward the introduction of our new ageLOC products in the second half of the year.

"Additionally, our financial performance and strong cash flow enabled us to repurchase approximately $50 million of shares in the second quarter. Overall, we are pleased with the direction of the business and continue to anticipate a return to revenue growth in the second half of the year."

For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.